Cumberland Partners Ltd Has $1.42 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Cumberland Partners Ltd decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 12.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,500 shares of the company’s stock after selling 500 shares during the quarter. Cumberland Partners Ltd’s holdings in HCA Healthcare were worth $1,423,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Bangor Savings Bank increased its stake in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC acquired a new stake in HCA Healthcare during the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC increased its position in HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare in the second quarter worth $33,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Wells Fargo & Company raised their price target on HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 6th. Royal Bank of Canada lifted their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Finally, Oppenheimer boosted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Trading Down 1.1 %

NYSE HCA traded down $3.76 on Tuesday, hitting $354.23. The company’s stock had a trading volume of 115,981 shares, compared to its average volume of 1,173,215. HCA Healthcare, Inc. has a 52-week low of $229.28 and a 52-week high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The firm has a market cap of $89.73 billion, a P/E ratio of 16.08, a PEG ratio of 1.36 and a beta of 1.68. The company’s 50-day simple moving average is $388.86 and its 200 day simple moving average is $356.86.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.